Dactolisib (BEZ235)
Dactolisib (BEZ235, NVP-BEZ235) is a dual ATP-competitive PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM in cell-free assays, respectively. Inhibits ATR with IC50 of 21 nM in 3T3TopBP1-ER cell. Dactolisib induces autophagy and suppresses HIV-1 replication. Phase 2.
| Trivial name | NVP-BEZ235 |
| Catalog Number | S1009 |
| Molecular Formula | C8H14O2 |
| CAS# | 915019-65-7 |
| Inchi | InChI=1S/C8H14O2/c9-8(10)6-7-4-2-1-3-5-7/h7H,1-6H2,(H,9,10) |
| Inchi Key | LJOODBDWMQKMFB-UHFFFAOYSA-N |
| SMILES | C1CCC(CC1)CC(=O)O |
| Size | 50mg |
| Supplier Page | http://www.selleckchem.com/products/BEZ235.html |
| Additional Information | https://file.selleck.cn/downloads/struct/BEZ235-NVP-BEZ235-chemical-structure-S1009.gif |
